Guardant Health

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$232,088
$203,471
$201,814
$191,476
Gross Profit
150,883
128,748
124,221
116,987
EBITDA
-88,836
-83,842
-99,191
-96,480
EBIT
-98,878
-94,078
-109,645
-107,078
Net Income
-99,899
-95,159
-111,006
-107,754
Net Change In Cash
232,088
203,471
201,814
191,476
Free Cash Flow
-65,934
-67,148
-83,388
-55,258
Cash
629,143
698,572
525,540
688,368
Basic Shares
124,114
123,871
123,754
123,051

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$739,016
$563,948
$449,538
$373,653
Gross Profit
449,217
336,896
293,213
250,741
EBITDA
-390,121
-433,305
-614,910
-359,622
EBIT
-432,508
-476,186
-650,872
-381,893
Net Income
-436,373
-479,449
-654,588
-405,670
Net Change In Cash
739,016
563,948
449,538
373,653
Cost of Revenue
-348,740
-338,996
Free Cash Flow
-274,943
-345,461
-386,924
-284,052
Cash
525,540
1,133,537
141,647
492,202
Basic Shares
122,745
111,988
102,178
101,314

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.44
2025-03-31
-$0.49
2024-12-31
-$0.62